Harrell Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,811
Closed -$2.94M 100
2021
Q1
$2.94M Buy
11,811
+1,077
+10% +$257K 1.04% 37
2020
Q4
$2.47M Sell
10,734
-1,985
-16% -$458K 0.95% 37
2020
Q3
$3.23M Buy
12,719
+23
+0.2% +$5.7K 1.41% 29
2020
Q2
$2.99M Buy
+12,696
New +$2.9M 1.52% 27

Other funds holding AMGN

Harrell Investment Partners's AMGN Position: Q2 2021 in Review

Harrell Investment Partners sold out of Amgen (AMGN) in Q2 2021, closing a stake of 11,811 shares — an estimated $2.94M sold.

Harrell Investment Partners first reported a position in AMGN in Q2 2020 and held it in 4 quarters. The position peaked at $3.23M in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Harrell Investment Partners reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Harrell Investment Partners sold 11,811 Amgen shares in Q2 2021, an estimated $2.94M.
  • Harrell Investment Partners first reported a position in Amgen in Q2 2020 and held it in 4 quarters.
  • Harrell Investment Partners's Amgen position peaked at $3.23M in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Harrell Investment Partners's 13F filing for Q2 2021, filed 16 Aug 2021.